News from neurocrine biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:NBIX)

Feb 03, 2016, 13:00 ET

Neurocrine Biosciences to Present at the Leerink Partners 5th Annual Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting...

Feb 02, 2016, 08:30 ET

Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in Children and Adolescents with Tourette Syndrome

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has initiated a Phase II clinical trial for NBI-98854 (valbenazine), a...

Jan 04, 2016, 14:00 ET

Neurocrine Biosciences to Present at the 34th Annual J.P. Morgan Healthcare Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Dec 16, 2015, 16:05 ET

Neurocrine Announces Successful Completion of Phase Ib T-Force Study of VMAT2 Inhibitor NBI-98854 in Adolescents and Children with Tourette Syndrome

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has successfully completed the Phase Ib T-Force study of NBI-98854...

Nov 25, 2015, 13:00 ET

Neurocrine Biosciences to Present at the 27th Annual Piper Jaffray Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting...

Nov 11, 2015, 14:10 ET

Neurocrine Biosciences to Present at the Jefferies Autumn 2015 Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting...

Nov 04, 2015, 15:30 ET

Neurocrine Biosciences to Present at Credit Suisse's 24th Annual Healthcare Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting at...

Nov 04, 2015, 08:00 ET

Neurocrine Biosciences Announces Expansion of its Clinical Pipeline

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, announced today...

Oct 29, 2015, 16:01 ET

Neurocrine Biosciences Reports Third Quarter 2015 Results

 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended September 30, 2015.  For the third...

Oct 22, 2015, 13:00 ET

Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2015 Results

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its third quarter 2015 financial results after the...

Oct 20, 2015, 08:30 ET

Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor NBI-98854 in Adults with Tourette Syndrome

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has expanded the clinical efforts for NBI-98854 (Valbenazine), a highly...

Oct 08, 2015, 06:30 ET

Neurocrine Announces Positive Results from Phase III Kinect 3 Study of NBI-98854 in Tardive Dyskinesia

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-98854, a highly selective small molecule VMAT2 inhibitor, showed a...

Sep 30, 2015, 16:30 ET

Neurocrine Biosciences Announces the Appointment of George J. Morrow to its Board of Directors

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has appointed George J. Morrow to its Board of Directors. Mr. Morrow has...

Sep 10, 2015, 14:12 ET

Neurocrine Biosciences to Present at the Morgan Stanley Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting...

Sep 03, 2015, 08:30 ET

Neurocrine Biosciences Announces the Appointment of Dr. Alfred W. Sandrock to its Board of Directors

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has appointed Alfred W. Sandrock, Jr., M.D., Ph.D. to its Board of...

Sep 02, 2015, 13:00 ET

Neurocrine Biosciences to Present at the Baird 2015 Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Tim Coughlin, Chief Financial Officer of Neurocrine Biosciences, will be...

Aug 13, 2015, 08:00 ET

Neurocrine Announces Completion of Enrollment into Kinect 3 Tardive Dyskinesia Study

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has recently completed subject randomization of the Phase...

Jul 29, 2015, 16:01 ET

Neurocrine Biosciences Reports Second Quarter 2015 Results

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended June 30, 2015. For the second quarter of...

Jul 22, 2015, 13:00 ET

Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2015 Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its second quarter 2015 financial results...

Jun 08, 2015, 16:27 ET

Neurocrine Biosciences Provides Update on NBI-77860 Program for Congenital Adrenal Hyperplasia

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has suspended two planned clinical studies of the Company's CRF...